Regarding association of Nrf2 overexpression and clinicopathological data, we found that its expression was significantly associated with high tumor grade in cervical and EC and with advanced tumor stage in endometrial and ovarian carcinoma and no significant association with the age. The gene discussed is NFE2L2; the disease is ovarian carcinoma.